nif:isString
|
-
* = number of cost estimates included in the analysis;** = In France, Spain, Italy and United Kingdom, we found 22 cost estimates, originated by 8 different studies, that: (a) did not have similar methodology than the rest of studies, so, there were indicen studies (when most part of the studies were prevalence studies); and, (b) did not incorporate antiretrovirals costs and another type of cost (so, these studies either incorporate antirretroviral costs or any other type of cost).
|